Human prothrombin complex concentrate (PCC) is indicated for rapid reversal of vitamin K antagonists (e.g., warfarin) and for the treatment of life-threatening bleeding associated with deficiency of clotting factors II, VII, IX, and X. Its main advantage is immediate restoration of coagulation capacity, allowing fast normalization of INR and effective bleeding control. In emergency situations such as intracranial hemorrhage, major trauma, or urgent surgery, PCC provides a much faster and more targeted correction compared to fresh frozen plasma. It requires low infusion volume, which reduces the risk of fluid overload, especially in critically ill or cardiac patients. Due to its rapid onset and predictable effect, PCC is a critical, life-saving therapy widely used in ICU, emergency, and surgical settings.